Can we please add below the headline. Thank you to our speakers, sponsors, and delegates who joined us in Seoul for the summit! If you are interested in the 2027 event, please get in touch at info@hansonwade.com
Antibody-drug conjugates, targeted protein degradation, induced proximity, bispecifics, and T-Cell Engagers have fast become the leading focus of R&D emerging from South Korea. The World Targeted Therapeutics South Korea Summit by Hanson Wade was a brand-new event experience delivering a comprehensive three-day coverage of the hottest topics in oncology by uniting three conferences together in the same venue at the same time: the 5th World ADC South Korea Summit, the World TPD & Induced Proximity Summit South Korea, and the World Bispecific & T-Cell Engager Summit South Korea.
This was a unique opportunity to focus on differentiated platforms and pipelines to create future first-and-best-in-class therapeutics that make you stand out from your competition and more appealing for global pharma partnerships.
Acting as Korea's most comprehensive R&D forum, attendees joined 400+ of their peers to transform the future and position South Korea as a global leader in targeted therapeutic R&D with both a strategic overview and technical insights across discovery, preclinical translation, clinical development, and manufacturing in each field.
What You Missed
Cross-Modality Scientific Insight:
Whether you work on antibody-drug conjugates (ADCs), targeted protein degradation (TPD) and induced proximity, bispecifics, or T-cell engagers, gain a holistic view of how to develop next-generation targeted therapeutics.
Translational & Clinical Learnings:
Access real-world case studies and clinical data from early discovery through late-stage development, with a focus on overcoming shared challenges in efficacy, safety, and patient selection.
Strategic Partnering & Innovation Opportunities:
Connect with Korean and global pharma, biotech, and solution providers across all three modalities to identify collaboration opportunities, technology platforms, and novel combination approaches.
Future-Facing Perspectives:
Hear from industry leaders on emerging trends, regulatory considerations, and the long-term commercial outlook shaping the next era of targeted therapies.
2026 Event Highlights
5th World ADC South Korea Summit
With 16 years of experience providing antibody-drug conjugate focused conferences around the world, and 5 years in the APAC region, World ADC Asia was your one-stop shop for ADC content from early discovery to late-phase manufacturing.
World Bispecifics & T-Cell Engager Summit South Korea
Following successfully serving the Bispecific & T-Cell Engager communities for over a decade, the World Bispecific & T-Cell Engager Summit South Korea came to Korea for the first time as the country's only event dedicated to propelling the next-generation of differentiated bispecific and T-Cell Engager drugs.
Supercharge Bispecific & TCEs to Revolutionize Oncology Treatments
World TPD & Induced Proximity Summit South Korea
After serving the United States and European TPD communities for several years, the first World TPD & Induced Proximity Summit South Korea brung global leaders together with Korean innovators to develop novel degradation platforms that redefine the druggable proteome.
Your One-Stop Forum to De-Risk & Develop Best-in-Class TPD Therapeutics
Attending Companies Included
Explore the 2026 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.